Page 31 - Read Online
P. 31

Singh et al. Mini-invasive Surg. 2025;9:28  https://dx.doi.org/10.20517/2574-1225.2024.75  Page 25 of 25

                   or second primary lesions in the treated head and neck cancer patient. Laryngoscope. 2013;123:2161-4.  DOI  PubMed
               54.      Chao SS, Loh KS, Tan LK. Modalities of surveillance in treated nasopharyngeal cancer. Otolaryngol Head Neck Surg. 2003;129:61-4.
                   DOI  PubMed
               55.      Harvey RJ, Pitzer G, Nissman DB, et al. PET/CT in the assessment of previously treated skull base malignancies. Head Neck.
                   2010;32:76-84.  DOI  PubMed
               56.      Kaplan DJ, Kim JH, Wang E, Snyderman C. Prognostic indicators for salvage surgery of recurrent sinonasal malignancy. Otolaryngol
                   Head Neck Surg. 2016;154:104-12.  DOI  PubMed
               57.      Tzelnick S, Levin EG, Yacobi D, Mizrachi A, Popovtzer A, Soudry E. Recurrence patterns and efficacy of surveillance modalities for
                   sinonasal malignancies. Am J Rhinol Allergy. 2022;36:473-9.  DOI  PubMed
               58.      Giuffrida AY, Burgueno JE, Koniaris LG, Gutierrez JC, Duncan R, Scully SP. Chondrosarcoma in the United States (1973 to 2003):
                   an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am. 2009;91:1063-72.  DOI  PubMed
               59.      Kim  SA,  Chung  YS,  Lee  BJ.  Recurrence  patterns  of  sinonasal  cancers  after  a  5-year  disease-free  period.  Laryngoscope.
                   2019;129:2451-7.  DOI  PubMed
               60.      Han AY, Nader ME, Lam K, Su SY. Current status of sinonasal cancer survivorship care. Head Neck. 2023;45:2458-68.  DOI
                   PubMed
               61.      Deppen SA, Blume J, Bobbey AJ, et al. 68Ga-DOTATATE Compared with 111In-DTPA-octreotide and conventional imaging for
                   pulmonary and gastroenteropancreatic neuroendocrine tumors: a systematic review and meta-analysis. J Nucl Med. 2016;57:872-8.
                   DOI  PubMed  PMC
               62.      Dadgar H, Norouzbeigi N, Ahmadzadehfar H, Assadi M. 68Ga-DOTATATE and 18F-FDG PET/CT for the management of
                   esthesioneuroblastoma of the sphenoclival region. Clin Nucl Med. 2020;45:e363-4.  DOI  PubMed
                                                     68
               63.      Liu KY, Goldrich DY, Ninan SJ, et al. The value of  Gallium-DOTATATE PET/CT in sinonasal neuroendocrine tumor management:
                   a case series. Head Neck. 2021;43:E30-40.  DOI  PubMed
   26   27   28   29   30   31   32   33   34   35   36